U.S. Markets close in 4 hrs 5 mins

Marina Biotech, Inc. (MRNA)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.340.00 (0.00%)
As of 9:40AM EDT. Market open.
People also watch
RXIIPARDCYCCOPXAGNVC

Marina Biotech, Inc.

17870 Castleton Street
Suite 250
City of Industry, CA 91748
United States
626-964-5788
http://www.marinabio.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees4

Key Executives

NameTitlePayExercisedAge
Dr. Vuong Trieu Ph.D.Exec. ChairmanN/AN/A54
Mr. Joseph W. RamelliCEO & Interim Pres82.5kN/A49
Mr. Mihir MunsifChief Operating OfficerN/AN/A54
Dr. Michael V. Templin Ph.D., DABTChief Technology OfficerN/AN/AN/A
Dr. Larn Hwang Ph.D.Chief Scientific OfficerN/AN/A54
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Marina Biotech, Inc., a biopharmaceutical company, engages in the discovery, acquisition, development, and commercialization of proprietary drug therapeutics for addressing unmet medical needs in the United States, Europe, and internationally. The company has three clinical development programs, such as IT-102 and IT-103, a celecoxib program drug candidates for the treatment of combined arthritis pain/hypertension and the treatment of pain requiring a high dose of celecoxib; CEQ508, an oral delivery of small interfering RNA against beta-catenin, combined with IT-102 to suppress polyps in the precancerous syndrome and orphan indication of familial adenomatous polyposis; and CEQ508 combined with IT-103 to treat colorectal cancer. Its preclinical pipeline includes oligotherapeutics for the treatment of bladder cancer, inflammatory bowel, and duchenne muscular dystrophy diseases. The company is based in City of Industry, California.

Corporate Governance

Marina Biotech, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.